Spyridon Michopoulos

In Vitro and In Vivo Inhibition of <i>Helicobacter pylori</i> by <i>Lactobacillus casei</i> Strain Shirota

Dionyssios N. Sgouras, Petros A. Maragkoudakis, Kalliopi Petraki et al. · Applied and Environmental Microbiology · 2004 · 329 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease

Konstantinos Κarmiris, Anastasios Avgerinos, Aikaterini Tavernaraki et al. · Journal of Crohn s and Colitis · 2015 · 153 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Brian Bressler, Andrés Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis · 2021 · 147 citations · Full text

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +16

Long‐acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia

Cyriaque Bon, Thomas Aparicio, Magalie Vincent et al. · Alimentary Pharmacology & Therapeutics · 2012 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes

Kaisa Thorell, Zilia Y. Muñoz-Ramírez, Difei Wang et al. · Nature Communications · 2023 · 70 citations · Full text

Life Sciences, Genetics, Microbiology +15